Premium
An updated synthesis of N 1 ′‐([ 11 C]methyl)naltrindole for positron emission tomography imaging of the delta opioid receptor
Author(s) -
Kaur Tanpreet,
Brooks Allen F.,
Hockley Brian G.,
Torres Jovany,
Henderson Bradford D.,
Scott Peter J.H.,
Shao Xia
Publication year - 2021
Publication title -
journal of labelled compounds and radiopharmaceuticals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.432
H-Index - 47
eISSN - 1099-1344
pISSN - 0362-4803
DOI - 10.1002/jlcr.3898
Subject(s) - naltrindole , chemistry , positron emission tomography , radiochemistry , chemical synthesis , opioid receptor , yield (engineering) , pet imaging , combinatorial chemistry , nuclear medicine , antagonist , receptor , physics , medicine , biochemistry , in vitro , thermodynamics
A new method for the synthesis of the highly selective delta opioid receptor (DOR) antagonist radiotracer N 1 ′‐([ 11 C]methyl)naltrindole ([ 11 C]MeNTI) is described. The original synthesis required hydrogenation of a benzyl protecting group after 11 C‐labeling, which is challenging in modern radiochemistry laboratories that tend to be heavily automated and operate according to current good manufacturing practice. To address this challenge, we describe development of a novel MeNTI precursor bearing a methoxymethyl acetal (MOM) protecting group, which is easily removed with HCl, and employ it in an updated synthesis of [ 11 C]MeNTI. The new synthesis is fully automated and validated for clinical use. The total synthesis time is 45 min and provides [ 11 C]MeNTI in good activity yield (49 ± 8 mCi), molar activity (3,926 ± 326 Ci/mmol) and radiochemical purity (97% ± 2%).